SCHEMBL7307437

SCHEMBL7307437

N#Cc1cccc(COc2ccc3c(c2)c(CCN)cn3Cc2ccc(C(=O)O)cn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH1 Q13686 1/20 0.49
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
EGFR P00533 4/20 0.43
IGF1R P08069 4/20 0.43
FLT4 P35916 4/20 0.43
KDR P35968 4/20 0.43
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
LTB4R Q15722 3/20 0.41
LTB4R2 Q9NPC1 3/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39
PLA2G2A P14555 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7320717 0.88 EGFR (0.50) ALKBH1FFAR1FFAR4EGFRIGF1R
SCHEMBL7318738 0.88 ALKBH1 (0.49) ALKBH1FFAR1FFAR4EGFRIGF1R
SCHEMBL7309660 0.87 PPARG (0.51) ALKBH1EGFRIGF1RFLT4KDR
SCHEMBL7318676 0.85 MAOB (0.45) EGFRIGF1RFLT4KDRCYP19A1
SCHEMBL7319275 0.83 EGFR (0.49) ALKBH1FFAR1FFAR4EGFRIGF1R
SCHEMBL7319193 0.83 FFAR1 (0.47) ALKBH1FFAR1FFAR4EGFRIGF1R
SCHEMBL7311769 0.82 EGFR (0.51) EGFRIGF1RFLT4KDRLTB4R
SCHEMBL7313126 0.82 EGFR (0.46) ALKBH1FFAR1FFAR4EGFRIGF1R
SCHEMBL7315482 0.81 FFAR1 (0.44) ALKBH1FFAR1FFAR4EGFRIGF1R
SCHEMBL7317891 0.81 EGFR (0.49) FFAR1FFAR4EGFRIGF1RFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US claimed
WO-2001034146-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2001-05-17 WO claimed
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US disclosed
WO-2001034146-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2001-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010007877-A1 NOVEL ANTI-INFECTIVES CTSL, MMP8, SERPINB1 ALKBH1 2269/4885FFAR1 4207/4885FFAR4 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.